Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Mv, Ezhov"'
Autor:
Oi, Afanas Eva, Ea, Klesareva, Ee, Efremov, Mv, Sidorova, Bespalova ZhD, Pavel Levashov, Mv, Ezhov, Adamova IIu, Sn, Pokrovskiĭ
Publikováno v:
Europe PubMed Central
The article deals with specification of technique of immune-enzyme analysis to detect autoantibodies to beta-adrenergic receptors (beta1-AP) using compound of oligopeptids representing the fragmentations of extracellular sites beta1-AP and chimeric m
Autor:
Igor Sergienko, Ae, Semenova, Vp, Masenko, Mv, Ezhov, Sa, Gabrusenko, Vv, Kukharchuk, Belenkov IuN
Publikováno v:
Europe PubMed Central
The aim of our study was to assess the influence of rosuvastatin on coronary angiogenesis. 30 male patients with chronic coronary heart disease and total cholesterol level5.2 mmol/l were treated with rosuvastatin 10 mg daily during 3 months. The seru
Publikováno v:
Europe PubMed Central
Reaction of parameters of lipid transport system to standard fat load (J.Patsch method), C-reactive protein (CRP) and fibrinogen levels were studied in 30 patients with ischemic heart disease before and after 3 months of therapy with atorvastatin (10
Autor:
Igor Sergienko, Samoĭlenko EIu, Vp, Masenko, Mv, Ezhov, Ab, Sumarokov, Ga, Tkachev, Oa, Pogorelova, Tv, Balakhonova, Vg, Naumov
Publikováno v:
Europe PubMed Central
Rosuvastatin (10 mg) was given for 3 months to 30 men (mean age 57+/-9 years) with total cholesterol (CH) above 5.2 mmol/l. Questioning, physical examination, registration of ECG, measurement of levels of total, low density lipoprotein (LDL), high de
Autor:
Vg, Naumov, Ab, Sumarokov, Mv, Ezhov, En, Aleksandrova, Alexander Novikov, Ir, Raimbekova, An, Samko, Vp, Masenko
Publikováno v:
Europe PubMed Central
Concentrations of interleukins 6 and 10, tumor necrosis factor alpha, transforming growth factor beta and C-reactive protein were measured in 42 patients before and in remote period after coronary stenting. Patients with angiographically documented i
Publikováno v:
Europe PubMed Central
Autor:
Češka R, Paragh G, Ž, Reiner, Banach M, Tokgözoğlu L, Av, Susekov, Rašlová K, Freiberger T, Vohnout B, Rynkiewicz A, Goudev A, Ga, Dan, Gaiţă D, Pojskić B, Pećin I, Kayıkçıoğlu M, Mitchenko O, Mv, Ezhov, Latkovskis G, Ž, Petrulionienė
Publikováno v:
ResearcherID
Europe PubMed Central
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d6570e75c931648993f06dc2d952a98d
http://europepmc.org/abstract/med/28225290
http://europepmc.org/abstract/med/28225290
Publikováno v:
Europe PubMed Central
Study aim was to investigate the association of lipoprotein (a) [Lp(a)] level with the development of cardiovascular complications in long-term follow-up period after coronary artery bypass grafting (CABG). Patients with chronic ischemic heart diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::46af3b710a1083e75bf705c3fa505eaa
http://europepmc.org/abstract/med/21626797
http://europepmc.org/abstract/med/21626797
Autor:
Češka R, Freiberger T, Av, Susekov, Paragh G, Ž, Reiner, Tokgözoğlu L, Rašlová K, Banach M, Vohnout B, Rynkiewicz A, Goudev A, Ga, Dan, Gaiţă D, Pojskić B, Pećin I, Kayıkçıoğlu M, Mitchenko O, Mv, Ezhov, Latkovskis G, Ž, Petrulionienė
Publikováno v:
Europe PubMed Central
ResearcherID
ResearcherID
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::082f2f0ad658b2ca49923db802ea764a
http://europepmc.org/abstract/med/28225288
http://europepmc.org/abstract/med/28225288
Autor:
Nasonova SN; Chazov National Medical Research Center of Cardiology., Meshkov AN; Chazov National Medical Research Center of Cardiology.; National Research Center for Therapy and Preventive Medicine., Zhirov IV; Chazov National Medical Research Center of Cardiology., Osmolovskaya YF; Chazov National Medical Research Center of Cardiology., Shoshina AA; Chazov National Medical Research Center of Cardiology., Gagloev AV; Chazov National Medical Research Center of Cardiology., Dzhumaniiazova IH; Centre for Strategic Planning and Management of Biomedical Health Risks., Zelenova EA; Centre for Strategic Planning and Management of Biomedical Health Risks., Erema VV; Centre for Strategic Planning and Management of Biomedical Health Risks., Gusakova MS; Centre for Strategic Planning and Management of Biomedical Health Risks., Ivanov MV; Centre for Strategic Planning and Management of Biomedical Health Risks., Terekhov MV; Centre for Strategic Planning and Management of Biomedical Health Risks., Kashtanova DA; Centre for Strategic Planning and Management of Biomedical Health Risks., Nekrasova AI; Centre for Strategic Planning and Management of Biomedical Health Risks., Mitrofanov SI; Centre for Strategic Planning and Management of Biomedical Health Risks., Shingaliev AS; Centre for Strategic Planning and Management of Biomedical Health Risks., Yudin VS; Centre for Strategic Planning and Management of Biomedical Health Risks., Keskinov AA; Centre for Strategic Planning and Management of Biomedical Health Risks., Gomyranova NV; Chazov National Medical Research Center of Cardiology., Chubykina UV; Chazov National Medical Research Center of Cardiology., Ezhov MV; Chazov National Medical Research Center of Cardiology., Tereshchenko SN; Chazov National Medical Research Center of Cardiology., Yudin SM; Centre for Strategic Planning and Management of Biomedical Health Risks., Boytsov SA; Chazov National Medical Research Center of Cardiology.
Publikováno v:
Terapevticheskii arkhiv [Ter Arkh] 2024 Oct 10; Vol. 96 (9), pp. 901-908. Date of Electronic Publication: 2024 Oct 10.